PURE Bioscience, Inc. (OTCQB: PURE) (“PURE” or the “Company”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company has appointed Jeff ...
PURE Bioscience, Inc., creator of the patented non-toxic silver dihydrogen citrate antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2025. Net product ...
EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (PURE) (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20251029402721/en/ The articles, information, and content displayed on this webpage ...
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver ...
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results